Trademarkia Logo

Canada

C$
POTFIRE
REGISTERED

on 7 Sept 2021

Last Applicant/ Owned by

UNITED GREENERIES LTD.

5250 Mission RoadDuncan

BRITISH COLUMBIA

CA

V9L6V2

Serial Number

1858505 filed on 20th Sept 2017

Registration Number

TMA1108634 registered on 7th Sept 2021

Registration expiry Date

7th Sept 2031

Correspondent Address

LISA D. STATT FOY

(Field LLP)400 - 444 7 Avenue SWCALGARY

ALBERTA

CA

T2P0X8

POTFIRE

Trademark usage description

consumer products containing cannabis, namely, cannabis oil for cosmetic purposes; cannabis preparations and derivative products in the form of person Read More

Classification Information


Class [003]
Consumer products containing cannabis, namely, cannabis oil for cosmetic purposes; cannabis preparations and derivative products in the form of personal care preparations for the body, namely, face and body creams for cosmetic purposes, cosmetic oils, skin emollients, skin ointments, cosmetics in the form of skin rubs, cosmetics in the form of lotions, face and body salves for cosmetic purposes


Classification kind code

11

Class [005]
Pharmaceuticals for the relief of pain and treatment of palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritis, neuromuscular diseases and disorders, namely, cerebrovascular accident (stroke), Parkinson's disease, multiple sclerosis, myasthenia gravis, Huntington's disease, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, and pain, movement disorders, glaucoma, asthma, hypertension, mental illness, namely anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, and dementia, inflammatory diseases, namely inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, and inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; pharmaceuticals consisting of cannabinoids as the active ingredient, namely cannabidiol, tetrahydrocannabinol, cannabinol, cannabigerol, tetrahydrocannabivarin, cannabidivarin, and cannabichromene for medical purposes; pharmaceuticals, nutraceuticals containing cannabis, cannabis compounds, namely, Cannabigerols, Cannabichromenes, Cannabidiol, Tetrahydrocannabinol, Cannabinol, Cannabinodiol, cannabicyclol, cannabielsoin, and cannabitriol; cannabis based pharmaceuticals for the relief of pain and treatment of nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritis, neuromuscular diseases and disorders, namely, cerebrovascular accident (stroke), Parkinson's disease, multiple sclerosis, myasthenia gravis, Huntington's disease, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, and pain, movement disorders, glaucoma, asthma, hypertension, mental illness, namely anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, and dementia, inflammatory diseases, namely inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, and inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; cannabinoids for use in pharmaceuticals; cannabis compounds, namely medicines containing a tetrahydrocannabinol extract, namely tetrahydrocannabinol for medical purposes; nutraceuticals, namely antioxidant pills, dietary supplements for general health and well-being, adult vitamins, minerals, and herbal supplements for general health and well-being; cannabis products namely dried cannabis and dried hashish for medical use; synthetic narcotics for medical use; medical marihuana; nutritional and dietary supplements for general health and well-being; pharmaceutical preparations for the relief of pain and treatment of palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritis, neuromuscular diseases and disorders, namely, cerebrovascular accident (stroke), Parkinson's disease, multiple sclerosis, myasthenia gravis, Huntington's disease, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, and pain, movement disorders, glaucoma, asthma, hypertension, mental illness, namely anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, and dementia, inflammatory diseases, namely inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, and inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; medicines containing a tetrahydrocannabinol extract; medicines derived from and related to the cannabis plant, namely, anti-inflammatories, analgesics, sedatives, appetite stimulants, antinauseants, intraocular pressure reducers, anti-tumors, antioxidants, antidepressants and antihypertensives; cannabis products, namely medicines namely medicinal dried cannabis, and medicines containing a tetrahydrocannabinol extract, namely tetrahydrocannabinol [THC] oil for medical purposes, for clinical studies; Dried cannabis, namely medical marihuana; dried cannabis namely dried medical marihuana;


Classification kind code

11

Class [016]
Cards, namely membership and medical identification cards; cards for use in connection with customer loyalty, reward, bonus point, and discount programs


Classification kind code

11

Class [029]
Consumer products containing cannabis, namely, cannabis oil for food, edible cannabis oil for food


Classification kind code

11

Class [030]
Consumer products containing cannabis, namely, brownies and chocolate bars infused with cannabis


Classification kind code

11

Class [031]
Plant seeds, namely agricultural seeds; cannabis products, namely cannabis seeds; cannabis seeds and cannabis plants; plants, namely live cannabis plants and cuttings from live cannabis plants


Classification kind code

11

Class [035]
Mail order medical marihuana clubs; membership services, namely the operation and maintenance of a membership organization for retail and wholesale stores in the field of medical marihuana; retail and wholesale sales of medical marihuana and seeds; retail and wholesale store reward program; sale of medical marihuana and cannabis extracts; sale of medical marihuana and cannabis extracts, namely hashish and cannabis resins; retail and wholesale sales of cannabis; providing identification cards for use in connection with customer loyalty, rewards, bonus points, and discount programs; sale of consumer products containing cannabis, cannabinoids and cannabis compounds namely, cannabis oil for food, edible cannabis for food and brownies and chocolate bars infused with cannabis


Classification kind code

11

Class [040]
Producing pharmaceuticals to the order and specifications of others; producing pharmaceuticals, pharmaceutical products and nutraceuticals to the order and specifications of others; processing of cannabis;


Classification kind code

11

Class [042]
Developing pharmaceuticals, pharmaceutical products and nutraceuticals; developing pharmaceuticals containing cannabinoids or cannabis compounds; development of cannabis products, namely cannabis medicines, and medicines containing a tetrahydrocannabinol extract, for clinical studies; research services in the field of cannabis and medical marihuana; product development services in the field of cannabis and medical marihuana; research services, namely research of new products for others; research services in the area of cannabis namely marihuana; research services in the area of cannabis namely medical marihuana; product development services; product development services in the area of cannabis; product development services in the area of cannabis namely marihuana; product development services in the area of cannabis namely medical marihuana; developing pharmaceuticals to the order and specification of others


Classification kind code

11

Class [044]
Operation of a dispensary for dried cannabis and pharmaceuticals, nutraceuticals; online Operation of a dispensary for dried cannabis and pharmaceuticals, nutraceuticals; providing information via a website containing information in the field of medical marihuana; providing information via a website containing information in the field of marihuana and cannabis; dispensing cannabis products, namely hashish, cannabis, cannabis seeds, pharmaceuticals and nutraceuticals containing cannabis, cannabinoids or cannabis compounds; dispensing pharmaceutical products containing cannabis; dispensing cannabis; dispensing marihuana; breeding, growing and processing of cannabis; dispensing medicinal marijuana and cannabis based products, namely cannabis based pharmaceuticals and nutraceuticals; dispensing pharmaceuticals; dispensing pharmaceuticals containing cannabinoids or cannabis compounds; providing information via a computer database in the field of medical marihuana


Classification kind code

11

Mark Details


Serial Number

1858505

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 18
on 16th Sept 2020
Extension of Time Refused
Submitted for opposition 135
on 11th Jun 2020
Amendment to Application
Submitted for opposition 15
on 25th Feb 2020
Correspondence Created
Submitted for opposition 135
on 30th Jan 2020
Amendment to Application
Submitted for opposition 12
on 17th May 2019
Extension of Time
Submitted for opposition 22
on 2th Nov 2018
Search Recorded
Submitted for opposition 20
on 2th Nov 2018
Examiner's First Report
Submitted for opposition 31
on 25th Sept 2017
Formalized
Submitted for opposition 1
on 21st Sept 2017
Created
Submitted for opposition 30
on 20th Sept 2017
Filed